Evidence map›Paper›PMID 41395475›Full record

ArticleFrontiers in microbiology2025

Effects of resveratrol on growth performance, immune function, and intestinal microbiota in Cherry Valley ducks.

Tiantian Gu, Yu Wang, Yan Chen, Jian Li, Shiyu Wang, Yonghai Wang, Xintong Li, Chunyang Wang, Fayi Xiao

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tiantian GuDepartment of Veterinary Medicine, Shandong Vocational Animal Science and Veterinary College, Weifang, China.
Yu WangDepartment of Veterinary Medicine, Shandong Vocational Animal Science and Veterinary College, Weifang, China.
Yan ChenDepartment of Veterinary Medicine, Shandong Vocational Animal Science and Veterinary College, Weifang, China.
Jian LiDepartment of Veterinary Medicine, Shandong Vocational Animal Science and Veterinary College, Weifang, China.
Shiyu WangAnimal Science and Veterinary Technical Center of Linqu County, Weifang, China.
Yonghai WangAnimal Science and Veterinary Technical Center of Gaomi City, Weifang, China.
Xintong LiCollege of Animal Science and Technology, Shandong Agricultural University, Taian, China.
Chunyang WangDepartment of Veterinary Medicine, Shandong Vocational Animal Science and Veterinary College, Weifang, China.
Fayi XiaoDepartment of Veterinary Medicine, Shandong Vocational Animal Science and Veterinary College, Weifang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study investigated the effects of stage-specific supplementation with 0.1% resveratrol on growth performance, immune function, and intestinal microbiota in Cherry Valley ducks from 1 to 42 days of age. Methods: A total of 300 1-day-old Cherry Valley ducks were randomly allocated into a control group (C) and four treatment groups (R1~R4). Resveratrol was administered via diet at 14, 21, 28, or 35 days of age until 42 days. Growth performance, slaughter traits, serum immune indices, and intestinal microbiota were analyzed. Results: In growth performance, the R1~R4 groups exhibited significantly improved slaughtering rates compared to the control ( Discussion: Resveratrol supplementation improved slaughtering performance, immune competence, and intestinal homeostasis in Cherry Valley ducks. Resveratrol supplementation from day 21 (R2 group) showed the most favorable outcomes for growth-immunity-microbiota axis regulation, highlighting its potential as a precision nutrition strategy in waterfowl aquaculture.

Indexed as

Cherry Valley duckgrowth performanceimmunefunctionintestinal microbiotaresveratrol

Identifiers

PMID41395475
PMCPMC12695740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.